Carbon
Carbon MPU 100
A surgical tool handle additively manufactured with the MPU 100 material.
Carbon has launched its first medical-grade material for use on its Digital Light Synthesis (DLS) 3D printing platforms.
Medical Polyurethane 100 (MPU 100) is a white polymer resin which the Californian company says boasts mechanical strength, biocompatibility and sterilisability. It has been designed to enable the additive manufacture of medical systems, skin-contact devices, drug-contact devices, and single-use medical devices. These applications can range from prosthetics to surgical guides to inhalers – the company has previewed some early applications on its website, including a surgical tool handle and a pill bottle.
Carbon says it has entered the medical market to help deliver medical tools that are easy to produce and durable enough to withstand demanding environments. The engineering-grade MPU 100 has been tested to USP VI and ISO 10993-5 standards, and is compatible with ethylene oxide, e-beam, and gamma sterilisation methods. It also maintains its biocompatibility post-sterilisation and a master file is available at the FDA.
It is because of these key features, and the adeptness of its DLS machines, that Carbon believes it can have a significant and positive impact on the medical market.
“With MPU 100, Carbon is enabling new capabilities for medical device manufacturers by providing the mechanical properties, biocompatibility, sterilisation compatibility, and chemical resistance to produce safe and reliable end-use products for patients,” commented Jason Rolland, Vice President of Materials at Carbon. “The life sciences and medical device industries show enormous promise for using 3D printing for production at scale, and we will continue to prioritise the development of next-generation materials in this segment.”
MPU 100 is being offered in 800ML cartridges to Carbon customers throughout the United States, Canada, and Europe.
